Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Liye Zhong
Observed names:
L. Zhong,
Li-Ye Zhong,
Li-ye Zhong,
Li‐Ye Zhong
Institutions:
Guangdong Academy of Medical Sciences,
Guangdong Provincial People's Hospital,
First Affiliated Hospital of Jinan University,
Southern Medical University
Observed institutions:
Jinan University,
Guangdong General Hospital,
Guangdong Academy of Medical Sciences,
Guangdong Provincial People's Hospital,
First Affiliated Hospital of Jinan University,
Southern Medical University
show all 6
ORCID:
0000-0001-5143-1239
Observed ORCID:
0000-0001-5143-1239
OpenAlex ID:
A5031250568
A Phase II Trial of the Bruton Tyrosine-Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Relapsed/Refractory Waldenström Macroglobulinemia
2021
·
Gang An
, Daobin Zhou
, et al.
·
Clinical Cancer Research
·
39
Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia
2010
·
Xin Huang
, Shaohua Chen
, et al.
·
Journal of Hematology & Oncology
·
38
PDF
A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic Lymphoma
2020
·
Xiao-Peng Tian
, Ning Su
, et al.
·
Clinical Cancer Research
·
35
Structure-based discovery of neoandrographolide as a novel inhibitor of Rab5 to suppress cancer growth
2020
·
Jing Zhang
, Yue Sun
, et al.
·
Computational and Structural Biotechnology Journal
·
34
Reduced levels of recent thymic emigrants in acute myeloid leukemia patients
2008
·
Yangqiu Li
, Qingsong Yin
, et al.
·
Cancer Immunology Immunotherapy
·
32
Increased TOX expression associates with exhausted T cells in patients with multiple myeloma
2022
·
Yujie Zhao
, Pengjun Liao
, et al.
·
Experimental Hematology and Oncology
·
31
PDF
A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphoma
2021
·
Xiao-Peng Tian
, Shu-Yun Ma
, et al.
·
Blood
·
31
Left atrial remodeling and the prognostic value of feature tracking derived left atrial strain in patients with light-chain amyloidosis: a cardiovascular magnetic resonance study
2022
·
Zekun Tan
, Yuelong Yang
, et al.
·
The International Journal of Cardiovascular Imaging
·
30
Different expression patterns of VISTA concurrent with PD-1, Tim-3, and TIGIT on T cell subsets in peripheral blood and bone marrow from patients with multiple myeloma
2022
·
Shuxin Huang
, Yujie Zhao
, et al.
·
Frontiers in Oncology
·
25
Current status and prospect of anti-amyloid fibril therapy in AL amyloidosis
2024
·
Jinghua Wang
, Jian Li
, et al.
·
Blood Reviews
·
21
A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study
2021
·
Jun Cai
, Xiaopeng Tian
, et al.
·
British Journal of Cancer
·
14
Methylation of the Promoter Region of the Tight Junction Protein-1 by DNMT1 Induces EMT-like Features in Multiple Myeloma
2020
·
Miao Li
, Lin Qi
, et al.
·
Molecular Therapy — Oncolytics
·
14
PDF
Attenuation of cGVHD by C5a/C5aR blockade is associated with increased frequency of Treg
2017
·
Yulian Wang
, Peilong Lai
, et al.
·
Scientific Reports
·
14
PDF
Immune checkpoint expression patterns on T cell subsets in light-chain amyloidosis: VISTA, PD-1, and TIGIT as potential therapeutic targets
2024
·
Jinghua Wang
, Yujie Zhao
, et al.
·
Blood Science
·
12
Hsa‐miR‐335 enhances cell migration and invasion in lung adenocarcinoma through targeting Copine‐1
2021
·
Yang Wang
, Jing Zhang
, et al.
·
MedComm
·
11
PDF
Comparative Proteome Identifies Complement Component 3-Mediated Immune Response as Key Difference of Colon Adenocarcinoma and Rectal Adenocarcinoma
2021
·
Jun-Ze Liang
, Xiao-Ling Liang
, et al.
·
Frontiers in Oncology
·
11
PDF
The efficacy and safety of CAR-T cell therapy in patients with refractory ALL and concomitant HBV infection
2020
·
Peilong Lai
, Xiaomei Chen
, et al.
·
Leukemia
·
10
Asymptomatic multicentric Castleman disease: a potential early stage of idiopathic MCD
2024
·
Lu Zhang
, Qin-hua Liu
, et al.
·
Blood Advances
·
9
Identification of lactate regulation pattern on tumor immune infiltration, therapy response, and DNA methylation in diffuse large B-cell lymphoma
2023
·
Jinghua Wang
, Yanjun Wang
, et al.
·
Frontiers in Immunology
·
9
Initial Results of the first-in-human Phase 1 study of IBI3003, a novel trispecific antibody targeting GPRC5D, BCMA and CD3, in patients with relapsed or refractory multiple myeloma
2025
·
Jing Li
, Zhenyu Li
, et al.
·
Blood
·
8
Chidamide, a Histone Deacetylase Inhibitor, Combined With R‐ GemOx in Relapsed/Refractory Diffuse Large B‐Cell Lymphoma ( TRUST ): A Multicenter, Single‐Arm, Phase 2 Trial
2025
·
Qihua Zou
, Yuchen Zhang
, et al.
·
Cancer Medicine
·
8
Incidence and effect of secondary cardiac amyloidosis on outcomes of patients with t(11;14) multiple myeloma
2022
·
Jinghua Wang
, Shuo Yang
, et al.
·
Frontiers in Cardiovascular Medicine
·
8
PDF
BET Inhibitor JQ1 Selectively Reduce Tregs by Upregulating STAT3 and Suppressing PD‐1 Expression in Patients with Multiple Myeloma
2024
·
Youxue Huang
, Mengjun Zhong
, et al.
·
Advanced Biology
·
7
PDF
Ibrutinib as monotherapy versus combination therapy in Chinese patients with relapsed/refractory mantle cell lymphoma: A multicenter study
2022
·
Yuchen Zhang
, Panpan Liu
, et al.
·
Cancer Medicine
·
6
PDF
Optimization of high-dose methotrexate prophylaxis for central nervous system relapse in diffuse large B-cell lymphoma: a multicenter analysis
2022
·
Yu Fang
, Ning Su
, et al.
·
Annals of Hematology
·
6
Show more works
View as search
Works count:
79
Citation count:
503
H-index:
13
I10-index:
17
Year
Topic
Type